Current Issue

Year 2019

Volume: 5 , Issue: 3

Print ISSN:-2395-1443

Online ISSN:-2395-1451

Member of


Indian Journal of Clinical and Experimental Ophthalmology


To evaluate the effect of intravitreal bevacizumab, macular grid laser and both in combination in patients of clinically significant macular edema


Full Text PDF



Author Details: Gunjan Prakash, Ashwini G, Himanshu Kumar Yadav, Neeraj A Awasthi

Volume : 2

Issue : 4

Online ISSN : 2395-1451

Print ISSN : 2395-1443

Article First Page : 387

Article End Page : 390


Abstract

Purpose: To compare the efficacy between intravitreal bevacizumab, macular grid photocoagulation and both in combination for the treatment of clinically significant macular edema.
Methods: 21 cases of clinically significant macular edema were prospectively divided in three groups randomly. In group A, patients received bevacizumab 0.05ml intravitreally. In group B, patients received macular grid photocoagulation. In group C, patients received combination of macular grid photocoagulation and bevacizumab 0.05ml intravitreally. Central macular thickness and best corrected visual acuity were the main outcomes measured.
Results: The difference in central macular thickness and best corrected visual acuity among the groups at baseline was not statistically significant (p>0.05). There was significantly more improvement in central macular thickness and best corrected visual acuity in group C than in group A and group B at two months follow-up (p<0.05).
Conclusion: The better short term therapeutic outcomes in the group C indicates that combining intravitreal bevacizumab and macular grid photocoagulation might be more effective than intravitreal bevacizumab and macular grid photocoagulation alone for the treatment of clinically significant macular edema.

Doi No:-10.18231